Candriam S.C.A. Sells 23,838 Shares of Astera Labs, Inc. $ALAB

Candriam S.C.A. lowered its position in Astera Labs, Inc. (NASDAQ:ALAB) by 40.0% in the 1st quarter, HoldingsChannel reports. The fund owned 35,742 shares of the company’s stock after selling 23,838 shares during the period. Candriam S.C.A.’s holdings in Astera Labs were worth $3,917,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ALAB. Reflection Asset Management purchased a new position in shares of Astera Labs in the fourth quarter worth about $25,000. Smartleaf Asset Management LLC lifted its stake in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares in the last quarter. Wexford Capital LP purchased a new stake in shares of Astera Labs during the 3rd quarter valued at approximately $39,000. Hilltop National Bank boosted its holdings in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the period. Finally, Aventura Private Wealth LLC bought a new position in Astera Labs in the 4th quarter worth approximately $33,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Price Performance

NASDAQ:ALAB opened at $362.05 on Tuesday. The company has a market capitalization of $62.06 billion, a price-to-earnings ratio of 244.63, a PEG ratio of 4.65 and a beta of 3.66. The business has a 50 day moving average of $339.10 and a 200 day moving average of $216.30. Astera Labs, Inc. has a 1-year low of $88.18 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue was up 93.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 1.88 EPS for the current year.

Insider Activity at Astera Labs

In other news, Director Manuel Alba sold 8,491 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total value of $3,892,104.58. Following the completion of the sale, the director directly owned 286,863 shares of the company’s stock, valued at approximately $131,492,261.94. This trade represents a 2.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,040,691 shares of company stock valued at $507,675,380 in the last quarter. 10.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ALAB has been the subject of several recent research reports. JPMorgan Chase & Co. lifted their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Citigroup cut Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Evercore restated an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Susquehanna lifted their target price on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $275.75.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.